Text Size

Refinement and Assessment of New Magnetic Resonance Imaging (MRI) Technologies for Neurological Exams

This study is currently recruiting participants.
Verified August 2011 by University of Michigan
Sponsor:
Collaborators:
General Electric
Philips Medical Systems
Information provided by:
University of Michigan
ClinicalTrials.gov Identifier:
NCT00739518
First received: August 20, 2008
Last updated: August 30, 2011
Last verified: August 2011
History of Changes
  Purpose

This study is being done to assess new Magnetic Resonance Imaging (MRI) technologies such as new hardware or software designed to improve MRI examinations of the brain, spine, and head & neck regions. Software and hardware are always being improved, new machines replace old machines, software is updated and improved as well as devices used to produce better MRI images.


Condition Intervention
Nervous System Diseases
 Procedure: MRI

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by University of Michigan:

Estimated Enrollment: 500
Study Start Date: October 2004
Arms Assigned Interventions
Experimental: 1
NEW technology MRI
 Procedure: MRI
Neurological MRI with new technology evaluation

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • If you are a male or a non-pregnant female patient
  • Normal volunteer
  • presenting to MRI for a clinically-ordered neurological or head and neck MRI exam

Exclusion Criteria:

  • Patients, who have electrically, magnetically or mechanically activated implants such as heart pacemaker, magnetic surgical clips, prostheses or implanted neurological stimulator.
  • Pregnant patients or patients who are lactating.
  • A patient who is claustrophobic
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00739518

Contacts
Contact: Suresh Mukherji, MD 734 936-8865 mukerji@umich.edu

Locations
United States, Michigan
University of Michigan Health System Recruiting
Ann Arbor, Michigan, United States, 48109
Contact: Suresh Mukherji, MD     734-936-8865     mukherji@umich.edu    
Sponsors and Collaborators
University of Michigan
General Electric
Philips Medical Systems
  More Information

No publications provided

Responsible Party: Suresh Mukherji MD, University of Michigan
ClinicalTrials.gov Identifier: NCT00739518     History of Changes
Other Study ID Numbers: HUM00041731
Study First Received: August 20, 2008
Last Updated: August 30, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by University of Michigan:
Neurological
MRI

Additional relevant MeSH terms:
Nervous System Diseases

ClinicalTrials.gov processed this record on June 18, 2013